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ABSTRACT 18 
Salmonella enterica serovars Typhi and Typhimurium cause typhoid fever and gastroenteritis 19 
respectively. A unique feature of typhoid infection is asymptomatic carriage within the 20 
gallbladder, which is linked with S. Typhi transmission. Despite this, S. Typhi responses to 21 
bile have been poorly studied. RNA-Seq of S. Typhi Ty2 and a clinical S. Typhi isolate 22 
belonging to the globally dominant H58 lineage (129-0238), as well as S. Typhimurium 23 
14028, revealed that 249, 389 and 453 genes respectively were differentially expressed in the 24 
presence of 3% bile compared to control cultures lacking bile. fad genes, the actP-acs 25 
operon, and putative sialic acid uptake and metabolism genes (t1787-t1790) were upregulated 26 
in all strains following bile exposure, which may represent adaptation to the small intestine 27 
environment. Genes within the Salmonella pathogenicity island 1 (SPI-1), encoding a type 28 
IIII secretion system (T3SS), and motility genes were significantly upregulated in both S. 29 
Typhi strains in bile, but downregulated in S. Typhimurium. Western blots of the SPI-1 30 
proteins SipC, SipD, SopB and SopE validated the gene expression data. Consistent with this, 31 
bile significantly increased S. Typhi HeLa cell invasion whilst S. Typhimurium invasion was 32 
significantly repressed. Protein stability assays demonstrated that in S. Typhi the half-life of 33 
HilD, the dominant regulator of SPI-1, is three times longer in the presence of bile; this 34 
increase in stability was independent of the acetyltransferase Pat. Overall, we found that S. 35 
Typhi exhibits a specific response to bile, especially with regards to virulence gene 36 
expression, which could impact pathogenesis and transmission.   37 
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INTRODUCTION 38 
In humans, the outcome of infection with Salmonella enterica primarily depends on the 39 
infecting serovar; whilst non-typhoidal, broad host range serovars such as Salmonella 40 
enterica serovar Typhimurium (S. Typhimurium) cause self-limiting gastroenteritis, infection 41 
with human-restricted typhoidal serovars, such as Salmonella enterica serovar Typhi (S. 42 
Typhi) result in typhoid fever (1). The virulence of both serovars depends on the activity of 43 
two type III secretion systems (T3SS) carried on Salmonella pathogenicity islands 1 and 2 44 
(SPI-1 and SPI-2), which secrete a pool of over 40 effectors to subvert host cell processes 45 
resulting in invasion, immune evasion, and intracellular growth (2). The SPI-1 T3SS is active 46 
when Salmonella are extracellular, and its activity permits Salmonella invasion of non-47 
phagocytic cells and also promotes early adaptation to the intracellular environment (2). 48 
Expression of the SPI-1 T3SS and its associated genes (several of which are encoded outside 49 
of the SPI-1 pathogenicity island) is controlled by a hierarchy of regulators (HilD, HilA, 50 
HilC, RtsA, InvF). These regulators are controlled by a variety of factors including two-51 
component systems, RNA binding proteins, and global regulators, which respond to a range 52 
of environmental stimuli (3, 4).  53 
Typhoid is an acute illness characterized by high fever, malaise and abdominal pain (5). S. 54 
Typhi causes systemic infection during which the pathogen colonises the intestine and 55 
mesenteric lymph nodes, the liver, spleen, bone marrow and gallbladder (5). It is estimated 56 
that there are more than 20 million typhoid fever cases per year, resulting in more than 57 
200,000 deaths (6). Although with adequate treatment most patients recover from the acute 58 
phase of S. Typhi infection, S. Typhi can persist asymptomatically within the gallbladder 59 
following clinical recovery (7). Overall, 10% of those infected will carry S. Typhi within 60 
their gallbladder for up to three months, whilst 1-3% will continue to harbour S. Typhi for 61 
longer than one year (5, 8). Given the host-restriction of S. Typhi, chronic gallbladder 62 
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carriage represents a key environmental reservoir of S. Typhi bacteria, enabling typhoid 63 
transmission (7, 9). 64 
Although the exact mechanism(s) by which S. Typhi persists within the gallbladder are 65 
debated (7), it certainty encounters high bile concentrations during carriage, as the 66 
gallbladder is where bile is stored and concentrated prior to secretion into the small intestine, 67 
where it plays a role in the emulsification and absorption of fats (10). In part due to its 68 
detergent activity, bile is also a potent antimicrobial agent (10, 11). However enteric 69 
pathogens – including Salmonella – are intrinsically resistant to bile (12), and instead often 70 
utilise bile as a means to regulate gene expression and virulence (10, 13). In S. Typhimurium, 71 
expression of the SPI-1 and motility genes are repressed by bile exposure, resulting in a 72 
significant repression of  epithelial cell invasion (14, 15). 73 
Despite the importance of asymptomatic carriage, the behaviour of S. Typhi within bile 74 
remains poorly understood (7). As the transcriptomic responses of S. Typhimurium to bile 75 
under various conditions have been well characterised (15–18), the behaviour of S. 76 
Typhimurium has become an accepted model as to how Salmonella in general behaves in bile 77 
(11, 19). However a study comparing changes in protein expression by 2D gel electrophoresis 78 
within S. Typhimurium and S. Typhi following exposure to 3% bile found there was “little 79 
overlap apparent between proteins affected by bile in S. Typhi and in S. Typhimurium” (12), 80 
suggesting that the response to bile between these serovars differs. Furthermore, a study 81 
comparing the genomes of S. Typhimurium LT2 to S. Typhi CT18 revealed that less than 82 
90% of genes are shared between the two strains, with over 600 genes present in CT18 not 83 
found in LT2 (20); therefore S. Typhimurium cannot be used to model regulation of S. Typhi 84 
specific genes, which include key virulence factors such as the Vi antigen, and the CdtB and 85 
HlyE/ClyA toxins (20).  86 
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The need to better understand S. Typhi infection has been intensified by the recent spread of 87 
haplotype 58 (H58), also known as 4.3.1 (21, 22). Following its emergence around 30 years 88 
ago, S. Typhi strains belonging to haplotype H58 have clonally expanded worldwide to 89 
become the dominant cause of multi-drug resistant (MDR) typhoid within endemic regions 90 
(21). As yet, the reasons underlying the relative success of H58 strains remain unknown.  91 
The aim of this study was to compare global bile responses between S. Typhi and S. 92 
Typhimurium isolates, which in turn might explain differences in pathogenesis and reveal 93 
processes important for the carrier state.  94 
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RESULTS 95 
Bile exposure alters global gene expression in Salmonella  96 
We performed RNA-Seq on S. Typhimurium 14028, S. Typhi Ty2 and a clinical S. Typhi 97 
H58 isolate (129-0238) grown in LB to late-exponential phase in the presence or absence of 98 
3% bile. Given the extensive description of S. Typhimurium behaviour in bile (14, 15), S. 99 
Typhimurium 14028 was considered as a control. 3% ox-bile was chosen for these studies as 100 
this concentration robustly affects gene expression in S. Typhimurium (14, 15, 23), but does 101 
not affect growth of the investigated Salmonella strains (Figure S1). Overall following 102 
growth in bile, 249 and 389 genes were differentially expressed in S. Typhi Ty2 (182 103 
upregulated; 67 downregulated) and 129-2038 (223 upregulated; 166 downregulated) (Figure 104 
1) respectively, while 453 genes were differentially regulated in S. Typhimurium 14028 (293 105 
upregulated; 179 downregulated) (Figure 1). 106 
GO enrichment and KEGG pathway analysis on the pools of upregulated and downregulated 107 
genes revealed broad differences between S. Typhi and S. Typhimurium (Figure 1). While S. 108 
Typhimurium upregulated metabolic processes and downregulated processes linked with 109 
pathogenicity, including T3SS, flagella and chemotaxis (motility), in line with previous 110 
findings (14, 15, 17), both S. Typhi Ty2 and 129-0238 upregulated these processes, whilst 111 
downregulating various metabolic pathways (Figure 1). KEGG pathway analysis also 112 
revealed that fatty acid degradation (represented by the GO term ‘Fatty acid beta-oxidation’) 113 
and tyrosine metabolism were upregulated in all isolates, implicating these processes in 114 
general Salmonella response to bile. 115 
Similarities in the response to bile between S. Typhi and S. Typhimurium 116 
The overlap in genes either downregulated or upregulated in bile between all strains was 117 
small; only one gene (pagP), a PhoP-PhoQ regulated gene involved in modifying lipid A 118 
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(24), was downregulated in all strains (Figure 2). Twenty genes were upregulated in all 119 
isolates in response to bile (Figure 2) (Table 1), representing genes involved in tyrosine 120 
metabolism, sialic acid uptake and utilisation (t1787-1790) (25), and in the production of 121 
acetyl-CoA from acetate (actP-acs) and fatty acids (fad genes). Of the upregulated genes, 122 
expression of acs and fadE was validated by RT-qPCR (Table 2). Upregulation of sialic acid 123 
and acetate metabolic pathways may reflect adaptation to the small intestine, where these 124 
metabolites are abundant (26), whilst upregulation of fad genes are consistent with the ability 125 
of Salmonella to utilise phospholipids present in bile as a carbon/energy source (27). 126 
Interestingly the fatty acid transporter fadL, was strongly upregulated in S. Typhimurium, but 127 
was not upregulated in either S. Typhi Ty2 or 129-0238, suggesting that S. Typhi may 128 
possess additional fatty acid transporters.  129 
Genes implicated in stress responses were also upregulated in bile. All isolates upregulated 130 
msrA, a sulfoxide reductase upregulated in response to oxidative stress, which is required for 131 
growth within macrophages and for full virulence of S. Typhimurium in vivo (28). S. 132 
Typhimurium 14028 and S. Typhi 129-0238 also activated RpoS-mediated stress responses, 133 
with upregulation of otsAB, spoVR, yeaG, katE, sodC, poxB, ecnB, and osmY, in line with 134 
previous findings (17, 29, 30). However, upregulation of these stress-linked genes was not 135 
observed in S. Typhi Ty2, which is likely due to a frameshift mutation within rpoS within this 136 
strain (31). 137 
Differences in the response to bile between S. Typhi and S. Typhimurium 138 
Of special interest are genes that are regulated differently in response to bile between S. 139 
Typhi and S. Typhimurium. The identification of such genes was achieved by determining 140 
genes downregulated in S. Typhimurium in bile, but upregulated in S. Typhi and vice versa. 141 
Of the 75 genes upregulated in both S. Typhi Ty2 and 129-0238 (Figure 2), the majority 142 
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(54/75) were significantly downregulated in S. Typhimurium (Table 3). As indicated by the 143 
GO and KEGG pathway analyses (Figure 1), genes regulated in this manner predominantly 144 
encode proteins associated with the SPI-1 T3SS or motility. To validate these findings, 145 
expression of the SPI-1 associated genes hilD, hilA, prgH, and sopB, in addition to the 146 
flagella associated genes flhD and flgA was confirmed by RT-qPCR (Table 2). 147 
Additional genes upregulated in S. Typhi and downregulated in S. Typhimurium include lpxR 148 
(t1208/STM14_1612), a lipid A modifying protein that modulates the ability of lipid A to 149 
stimulate TLR4 (32) and promotes Salmonella growth inside macrophages (33), and 150 
srfA/srfB, virulence factors expressed under SPI-1 inducing conditions (34) and reported to 151 
modulate inflammatory signalling (35). Additionally, several hypothetical proteins – t0944 152 
(STM14_2352), t1774 (STM14_1312) and t2782 (STM14_3479) – were upregulated in S. 153 
Typhi but downregulated in S. Typhimurium. Given their regulation pattern, these genes may 154 
encode uncharacterised virulence factors or be involved in motility in Salmonella. 155 
We also analysed the expression profile of S. Typhi specific genes. S. Typhi Ty2 carries 453 156 
unique genes relative to S. Typhimurium (representing Ty2 homologues of the 601 S. Typhi 157 
specific genes identified in CT18 (36), in addition to 29 Ty2 specific genes (37)). Only two of 158 
these genes were significantly regulated by bile exposure in both S. Typhi Ty2 and 129-0238. 159 
Both genes, which are upregulated in bile, encode hypothetical proteins: t0349 (STY2749) 160 
encodes a GIY-YIG domain containing protein, and t1865 (STY1076) encodes a homologue 161 
of the NleG family of T3SS effectors (38, 39). Neither S. Typhi isolate demonstrated altered 162 
expression of genes encoding the Vi antigen or of the typhoid toxin in bile.   163 
Bile influences SPI-1 expression and Salmonella invasion 164 
The most marked differences between S. Typhi and S. Typhimurium in response to bile was 165 
in the expression of SPI-1-associated genes. The majority of genes within the SPI-1 166 
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pathogenicity island, in addition to the SPI-1 regulators rtsA and rtsB, and effector genes 167 
carried outside SPI-1 (sopD), were significantly upregulated in S. Typhi Ty2 and 129-0238 168 
but significantly downregulated in S. Typhimurium (Table 3; Figure 3A). Noticeably, S. 169 
Typhi 129-0238 exhibited significantly elevated expression of SPI-1 genes relative to S. 170 
Typhi Ty2 (Table 3; Figure 3A).  171 
To determine if changes in SPI-1 gene expression correlated with changes at the protein 172 
level, we compared the intracellular levels of the SPI-1 translocon proteins SipC, SipD, and 173 
the SPI-1 effectors SopE (for S. Typhi) or SopB (for S. Typhi and S. Typhimurium) from 174 
each strain grown in the absence or presence of bile. Additional S. Typhi strains were also 175 
included to further expand and validate these findings, namely the RpoS+ S. Typhi reference 176 
strain CT18 (37), and an additional H58 isolate, ERL12148 which belongs to a different 177 
sublineage of H58 than 129-0238 (21). All S. Typhi strains tested (Ty2, CT18, 129-0238, 178 
ERL12148) showed increased levels of SPI-1 proteins, with the H58 strains demonstrating 179 
the largest increases in SPI-1 protein expression in bile (Figure 3B, Figure S2). Conversely S. 180 
Typhimurium 14028 showed decreased levels of SopB, SipD and SipC following growth in 181 
bile (Figure 3B, Figure S2); as S. Typhimurium 14028 lacks SopE, its lanes (Tm) in the SopE 182 
panel are not shown. 183 
Given the significant effect of bile on SPI-1 expression, we investigated the impact of bile on 184 
epithelial cell invasion. In line with previous findings (14), S. Typhimurium exposed to bile 185 
demonstrated significantly reduced invasion, achieving an invasion rate approximately 90% 186 
lower than S. Typhimurium grown in the absence of bile (Figure 3C). In contrast, all S. Typhi 187 
strains tested demonstrated significantly increased invasion following bile exposure, with 188 
Ty2 and CT18 displaying an approximate 2-fold increase in the number of intracellular 189 
bacteria at 2 h post-infection, and both H58 isolates demonstrating even higher increases in 190 
invasion (between 4-16 fold) (Figure 3C, Figure S2). A SPI-1 deficient strain of S. Typhi Ty2 191 
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(ΔinvA) did not invade HeLa cells in the presence of bile, indicating that the increased 192 
invasiveness of S. Typhi in bile is SPI-1 dependent (Figure S2). 193 
Transcriptional regulation of SPI-1 regulators in bile 194 
Given the striking difference in SPI-1 expression between S. Typhi and S. Typhimurium in 195 
response to bile, we determined where and how SPI-1 regulation differs between the two 196 
serovars. The central regulators governing SPI-1 expression are HilA, often termed the 197 
master SPI-1 regulator, and HilD, which is the dominant regulator of HilA (3, 40). The RNA-198 
Seq and RT-qPCR data show that the mRNA levels of these regulators significantly decrease 199 
in S. Typhimurium in response to bile, but significantly increase in response to bile in the S. 200 
Typhi strains (Table 2).  201 
In order to determine if these changes are mediated by transcriptional regulation of these 202 
genes, we constructed hilA and hilD lacZ chromosomal transcriptional reporters in S. 203 
Typhimurium 14028 and S. Typhi Ty2 (41). The reporter activity was determined by β-204 
galactosidase assay following growth to late exponential phase in LB with or without 3% 205 
bile. In S. Typhimurium expression of hilA is significantly reduced in the presence of bile, 206 
with expression almost 20 fold lower, while expression of hilD is unchanged (Figure 4). In 207 
contrast, expression of hilA in S. Typhi significantly increases in bile, with expression over 3 208 
times higher, whilst hilD expression is only modestly increased (Figure 4). Taken together, 209 
these results indicate that hilA is transcriptionally regulated by bile in both S. Typhi and S. 210 
Typhimurium, whilst hilD is not subject to transcriptional regulation.  211 
The seeming absence of hilD transcriptional regulation in bile (Figure 4) is at odds with the 212 
significant changes in mRNA levels observed (Table 2). One explanation is that hilD:lacZ 213 
reporter strains do not account for HilD-mediated autoregulation, as the chromosomal 214 
reporter strains were made in a hilD background. HilD autoregulation has previously been 215 
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reported in S. Typhimurium (42), but has not been characterised in S. Typhi. To determine if 216 
HilD autoregulation could account for transcriptional changes of hilD in bile in S. Typhi, the 217 
hilD:lacZ S. Typhi Ty2 reporter strain was transformed with a plasmid expressing HilD or an 218 
empty vector control, and reporter activity assessed by β-galactosidase assay following 219 
growth in LB. hilD expression from the strain complemented with HilD was significantly 220 
higher than hilD expression from both the reporter strain alone and the reporter carrying the 221 
empty vector (Figure 5), indicating that in S. Typhi HilD positively regulates its own 222 
transcription, either directly or indirectly. 223 
Bile influences HilD stability 224 
Given that expression of hilA, a gene directly regulated by HilD, significantly increases in 225 
bile, we investigated if HilD is post-transcriptionally regulated by bile in S. Typhi. Previous 226 
studies have shown that in S. Typhimurium, HilD stability is markedly decreased in the 227 
presence of bile, with a reported half-life almost 4 times shorter in LB supplemented with 3% 228 
bile, than in LB alone (23). To determine the effect of bile on HilD stability in S. Typhi, S. 229 
Typhi Ty2 was transformed with constitutively expressed HA-tagged HilD (from S. Typhi 230 
Ty2), subcultured in the presence or absence of bile, and samples taken at regular intervals 231 
following the inhibition of protein synthesis. Importantly the HA-tagged HilD used in these 232 
studies was functional (Figure 5), indicating that the HA tag used does not disrupt HilD 233 
structure or activity. In LB the half-life of HilD was 14 min, while in bile the half-life of HilD 234 
increased to 40 min, indicating that HilD is approximately three times more stable in the 235 
presence of bile in S. Typhi (Figure 6A).  236 
HilD is highly conserved between S. Typhi and S. Typhimurium (>99% identity; 2 amino 237 
acid changes). Since HilD has previously been shown to be less stable in bile in S. 238 
Typhimurium (23), we next determined if this difference in stability was due to intrinsic 239 
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differences between HilD between the serovars, or rather due to differences in factors that act 240 
on HilD and influence its stability. To investigate this, we determined the stability of HA-241 
tagged HilD from S. Typhimurium 14028 expressed in S. Typhi Ty2. As for S. Typhi HilD, S. 242 
Typhimurium HilD was three times more stable in bile, with a recorded half-life increasing 243 
from 8 min in LB, to 21 min (Figure 6B).  244 
Although several factors have been reported to post-transcriptionally regulate HilD (e.g. 245 
HilE, CsrA, GreE/GreB, FliZ, Hfq, RNase E (3, 43, 44)), only two have been described to 246 
directly influence HilD protein stability: the protease Lon, which degrades HilD (45), and the 247 
acetyltransferase Pat, which acetylates HilD to increase stability whilst decreasing DNA 248 
binding (46). To determine if these factors were involved in mediating HilD stability in bile 249 
in S. Typhi Ty2, deletions were constructed and HilD stability determined as previously. 250 
Unfortunately, a Δlon Ty2 strain had severe growth defects and could not be tested. Although 251 
HilD stability was decreased in a Δpat Ty2 strain, in line with previous findings in S. 252 
Typhimurium (46, 47), stability of HilD was still increased in the presence of bile, increasing 253 
from 4 min in LB to 13 min in the presence of bile (Figure S3), indicating that Pat-mediated 254 
acetylation of HilD is not responsible for the increased stability in bile. Overall, our data 255 
suggest that factors responsible for governing the stability of HilD in response to bile (other 256 
than Pat) differ between S. Typhi and S. Typhimurium.  257 
 13 
DISCUSSION 258 
Transcriptomic analysis of S. Typhimurium and S. Typhi strains grown in LB or 3% bile 259 
permitted the identification of similarities and differences in each serovars’ response to bile.  260 
Significant differences were observed in the regulation of the invasion-associated SPI-1 T3SS 261 
and in motility genes between non-typhoidal and typhoidal serovars. S. Typhi strains 262 
significantly upregulated these processes, and displayed a significant increase in T3SS-263 
dependent invasion in bile, a response akin to other enteric pathogens (13), including Vibrio 264 
parahaemolyticus (48), Vibrio cholera (49, 50), and Shigella (51, 52). All S. Typhi strains 265 
tested (Ty2, CT18 and two H58 clinical isolates) demonstrated significantly increased 266 
invasion in bile, strongly suggesting that this is a common response of S. Typhi to bile.  267 
It is interesting to consider why S. Typhi and S. Typhimurium have such disparate responses 268 
to bile. During infection, Salmonella encounters bile within the small intestine, and in the 269 
case of S. Typhi, within the gallbladder. Following the observation that S. Typhimurium 270 
invasion was significantly repressed in the presence of bile (14), a model was proposed that 271 
S. Typhimurium uses bile concentration as a means to sense proximity to the intestinal 272 
epithelium; in the lumen where bile concentration is highest, SPI-1 expression would be 273 
repressed, as the bacteria get closer to the intestinal cells, bile concentration would decrease, 274 
leading to SPI-1 expression and invasion (14). Within the context of this model however, S. 275 
Typhi would be less invasive when in close contact with the intestinal epithelium, which is 276 
consistent with the limited intestinal inflammatory responses induced by S. Typhi (1). 277 
Moreover, S. Typhi has a unique site of infection – the gallbladder (7, 9). One of the 278 
mechanisms by which S. Typhi has been proposed to persist within the gallbladder is via 279 
direct invasion of gallbladder epithelial cells (53, 54); bile-induced increases in SPI-1 280 
expression and invasiveness may therefore promote S. Typhi invasion and colonisation of the 281 
gallbladder epithelium. Alternatively, as S. Typhi carriage is closely associated with the 282 
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presence of gallstones, it is believed that S. Typhi forms biofilms on gallstone surfaces (7, 283 
55). Biofilm formation on gallstones depends on several factors including the presence of 284 
flagellar filaments (56), increased flagellar expression may therefore also promote biofilm 285 
formation. As such, increases in expression of SPI-1 and motility associated genes in bile 286 
may promote S. Typhi colonisation of the gallbladder, and therefore reflect adaptation to this 287 
environment.  288 
In terms of understanding how S. Typhi and S. Typhimurium differ with regards to SPI-1 289 
expression in bile, our results, in combination with previous findings (23), demonstrate that 290 
HilD is differentially regulated by bile at the level of protein stability (consistent with the 291 
idea that HilD is largely controlled at the post-transcriptional level (40)), resulting in 292 
significant differences in the expression of downstream genes, including the SPI-1 master 293 
regulator, hilA (Figure 7). The factor(s) responsible for mediating changes in HilD stability in 294 
response to bile remains to be established, however this response does not appear to rely on 295 
Lon (23) or Pat (this study). A recent transposon screen which aimed to identify factors 296 
responsible for bile-mediated SPI-1 repression in S. Typhimurium failed to identify any 297 
regulatory factor other than HilD (23). There are several reasons why such an approach may 298 
have failed, including the involvement of essential genes or redundancy. Unfortunately 299 
attempts to further identify regulatory mechanisms in S. Typhi are confounded by the limited 300 
characterisation of SPI-1 regulatory processes within S. Typhi. The overall effect of bile on 301 
invasion between S. Typhi and S. Typhimurium may also not be entirely regulatory; for 302 
example the translocon protein SipD has been reported to interact with bile salts (57), but 303 
SipD is one of several T3SS-associated proteins reported to be 'differentially evolved’ (as 304 
determined by non-synonymous amino acid changes) between typhoidal and non-typhoidal 305 
serovars, which results in functional differences (58). Importantly, in Shigella flexneri, 306 
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interaction of deoxycholate or other bile salts with the SipD homologue, IpaD, promotes the 307 
recruitment of the translocator protein, IpaB, ‘readying’ the T3SS for secretion (59, 60). 308 
Our results also demonstrate that strains belonging to the H58 S. Typhi lineage (129-0238 309 
and ERL12148) display significantly increased responses to bile when compared to S. Typhi 310 
reference strains (Ty2 and CT18). When considering chronic carriage such responses may be 311 
advantageous, by increasing the potential of H58 strains to colonise the gallbladder, 312 
increasing bacterial burden and subsequently increasing transmission. However, it is 313 
currently unknown if this reflects differences between recently isolated clinical strains when 314 
compared to more laboratory-adapted reference strains, or is instead due to intrinsic 315 
difference in H58 strains compared to other S. Typhi haplotypes. H58 isolates have 44 non-316 
synonymous single nucleotide polymorphisms (SNPs) which are not found within the S. 317 
Typhi reference strain CT18 (21), including several SNPs within the Csr system (sirA 318 
(L63F), csrB (155G>A), csrD (A620V)), which is a known regulator of SPI-1 (61). 319 
Interestingly, significant phenotypic differences in bile were also observed between the two 320 
H58 strains investigated. Further comparisons of H58 strains would be required to determine 321 
if the phenotypic differences observed are sublineage-specific or simply reflect diversity 322 
within the H58 group. 323 
In conclusion, our results confirm that bile is a key regulator of gene expression in 324 
Salmonella, influencing the expression of almost 10% of the genome, including genes 325 
associated with virulence, motility and metabolism. These findings add to the characterisation 326 
of S. Typhi responses to bile (30, 62), which may ultimately help explain the mechanisms by 327 
which S. Typhi induces chronic carriage (13).  328 
  329 
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MATERIALS AND METHODS 330 
Bacterial strains, growth conditions and plasmid construction  331 
The strains and plasmids used in this study are listed in Table 4. Salmonella were routinely 332 
grown in LB Lennox (Sigma-Aldrich) at 37°C / 200 rpm. Ox bile (3% w/v) (Sigma-333 
Aldrich/Merck-Millipore) was supplemented as indicated.  334 
All oligonucleotides used in this study are listed in Table S1.  The ΔinvA and Δpat S. Typhi 335 
Ty2 deletion strains were constructed via lambda red, as previously described (63, 64). 336 
Strains with chromosomal integration of the lacZ gene were also constructed via lambda red 337 
recombination as described (41). Correct integration of introduced cassettes was validated by 338 
PCR.  339 
To create HA tagged HilD, pWSK29-Spec-4HA (64) was amplified with a reverse primer 340 
containing a PacI digestion site, and HilD was amplified from both S. Typhimurium and S. 341 
Typhi with primers containing NotI and PacI restriction sites. Both products were digested, 342 
and HilD cloned into the existing NotI site and the introduced PacI site of pWSK29-Spec-343 
4HA, resulting in constitutively expressed C-terminally tagged HilD-4HA. Plasmid 344 
construction was validated by sequencing.  345 
Cell culture and HeLa invasion assays 346 
HeLa cells (ATCC) were maintained in Dulbecco’s Modified Eagle medium supplemented 347 
with 10% foetal bovine serum (FBS) (Sigma-Aldrich) in a 5% CO2 at 37°C. The cells were 348 
authenticated via short tandem repeat profiling in February 2016 (Microsynth).  349 
Invasiveness of strains was determined by gentamicin protection assays, as previously 350 
described (64). Briefly, Salmonella strains were cultured overnight at 37°C / 200 rpm in LB 351 
or LB supplemented with 3% bile before subculturing 1:33 in LB or LB 3% bile until late 352 
exponential phase (OD600 ~1.8), when SPI-1 expression is induced (18) (data not shown). To 353 
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prevent bile-mediated cell lysis, bacteria were washed twice in LB before addition to cells at 354 
an MOI 100:1. As S. Typhi is less invasive than S. Typhimurium (65), S. Typhi infections 355 
were performed for  1 h, and S. Typhimurium for 15 min, prior to the addition of gentamicin, 356 
unless otherwise indicated. At indicated time points, cells were lysed, serially diluted, and 357 
plated to enumerate intracellular CFU. 358 
RNA extraction  359 
Salmonella were cultured overnight in LB or LB supplemented with 3% bile (w/v) before 360 
subculturing 1:33 until late exponential phase (OD600 ~1.8). 6 x 10
8 bacteria were incubated 361 
in RNAprotect (Qiagen) at room temperature (RT) for 5 min. Bacteria were digested with 362 
lysozyme (15 mg / ml) and proteinase K for 20 min at RT, and RNA extracted using the 363 
RNeasy Mini Kit (Qiagen) as per manufacturer’s instructions. RNA extractions for RNA-Seq 364 
were performed in duplicate then pooled, over three biological repeats. RNA extractions for 365 
quantitative reverse transcription PCR (RT-qPCR) were performed in triplicate over three 366 
biological repeats. RNA samples for RNA-Seq and RT-qPCR were extracted independently 367 
of each other. 368 
RNA sequencing and data analysis 369 
For RNA sequencing, mRNA libraries were multiplexed and prepared by utilisation of the 370 
Illumina TruSeq protocol followed by sequencing via paired-end methodology on the 371 
Illumina HiSeq version 4 platform. Each lane of Illumina sequence was assessed for quality 372 
on the basis of adapter contamination, average base read quality and any unusual G-C bias 373 
using FastQC. The median Phred score for all samples was >34.  To permit comparison 374 
between strains, sequenced reads for each strain were mapped to the Ty2 genome 375 
(NC_004631) using the Rockhopper tool (66) with default parameters (Data S1-3). The read 376 
alignment coverage for each sample can be found in Table S2. The threshold for 377 
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differentially expressed genes was gated as those displaying >2 fold change in expression in 378 
3% bile compared to LB alone, and with an adjusted p value (q value) < 0.05.   379 
GO term enrichment for differentially regulated genes was performed with Panther (67) using 380 
the S. Typhimurium GO annotation, whilst KEGG pathway analysis was performed with the 381 
GAGE R package (68) (R 3.3.1), using the S. Typhi (stt) KEGG annotation. The 382 
VennDiagram (69) and gplots R packages were used for data visualisation. 383 
Quantitative reverse transcription PCR (RT-qPCR) 384 
2 µg of RNA was treated with DNase (Promega) prior to reverse transcription with M-MLV 385 
reverse transcriptase (Promega) according to manufacturer’s recommendations. Fast SYBR 386 
Green Master Mix (Applied Biosystems) was used for qPCR reactions alongside the Applied 387 
Biosystems StepOnePlus system. 20 ng of cDNA was used per reaction, and forward and 388 
reverse primers (Table S1) used at final concentration of 0.2 µM. Samples without reverse 389 
transcription were included as negative controls. The housekeeping gene, ftsZ, was used as 390 
the reference gene as it was determined to be least variable gene between strains and between 391 
LB with and without 3% bile. qPCR reactions were performed in duplicate on triplicate 392 
samples over three biological replicates. 393 
SPI-1 protein expression and stability assays 394 
To determine expression of SPI-1 proteins, Salmonella were subcultured in the absence or 395 
presence of 3% ox-bile to late exponential phase. 1 mL of culture was pelleted and re-396 
suspended in 2X SDS loading buffer (1M Tris pH 6.8, 2% SDS, 20% glycerol, 5% β-397 
mercaptoethanol, bromophenol blue) in proportion to OD600. To determine HilD stability, 398 
Salmonella strains previously transformed with 4HA-tagged constructs were subcultured in 399 
10 ml LB with or without the addition of 3% ox-bile until late exponential phase. The OD600 400 
was recorded, and chloramphenicol (30 µg/ml) added to inhibit protein synthesis. 1 ml 401 
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bacteria were pelleted and re-suspended in 2X SDS loading buffer in proportion to OD600. 402 
The cultures were incubated at 37°C / 200 rpm, and 1 ml samples were taken at required time 403 
points. Samples were heated at 95°C for 10 min. Whole cell samples were subject to Western 404 
blotting, using an anti-HA antibody to detect the protein of interest, and DnaK as a loading 405 
control. Following imaging, band density was quantified using ImageJ, and half-life (in 406 
minutes) calculated using the equation: (t x ln(2)) / (ln(No/Nf)), where t equals time elapsed 407 
between measurements (in minutes), N0 equals the initial amount, and Nf equals the final 408 
amount (23). To determine changes in SPI-1 proteins in bile, band density was quantified 409 
using ImageJ, levels of SPI-1 proteins were normalised to the corresponding DnaK value, and 410 
fold change in bile relative to LB calculated.  411 
SDS-PAGE and Western blotting 412 
Proteins were separated on 12% acrylamide gels followed by semi-dry transfer on to PVDF 413 
membrane (GE Healthcare). Membranes were blocked in 5% milk in PBS + 0.05% Tween-20 414 
(Sigma-Aldrich), and probed with either anti-DnaK 8E2/2 (1:10000) (Enzo Life Sciences 415 
#ADI-SPA-880), anti-HA HA-7 (1:1000) (Sigma #H3663), anti-SipC, anti-SipD, anti-SopB, 416 
or anti-SopE (1:5000) (V. Koronakis, University of Cambridge) primary antibodies, followed 417 
by HRP-conjugated secondary antibody (1:10000) (Jackson ImmunoResearch). 418 
Chemiluminescence following the addition of EZ-ECL reagent (Geneflow) was detected 419 
using the LAS-3000 imager (Fuji).  420 
β-galactosidase assays 421 
β-galactosidase assays were performed as previously described (70). Salmonella strains were 422 
grown in SPI-1 inducing conditions with or without the addition of 3% ox bile. The OD600 423 
was recorded, and 1 ml of culture pelleted and resuspend in 1 ml Z buffer (0.06M Na2HPO4, 424 
0.04M NaH2PO4, 0.01M KCl, 0.001M MgSO4 and 0.05M β-mercaptoethanol, pH 7). WT 425 
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strains were used as negative controls. Samples were permeabilised with the addition of 0.1% 426 
SDS and chloroform, and vortexed for 2 min. 20 µl of prepared sample was added to 180 µl 427 
Z buffer in a 96 well microplate, and 2-Nitrophenyl β-D-galactopyranoside (ONPG) substrate 428 
(4 mg/ml in Z buffer) added. Plates were incubated at RT, then the reaction stopped with the 429 
addition of 1M Na2CO3. The absorbance of the samples was measured at 405 nm and 540 nm 430 
using a FLUOStar Omega plate reader (BMG Labtech). 431 
Statistical analysis 432 
Statistical tests were performed using GraphPad Prism (Version 7.00) for Windows 433 
(GraphPad Software, San Diego, California, USA). All data are expressed as mean ± SD. 434 
Significance (p < 0.05) was determined by unpaired t-test or ANOVA, with correction for 435 
multiple comparisons when required. 436 
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FIGURE LEGENDS 672 
Figure 1. Comparison of pathways differentially regulated by bile between S. Typhi and 673 
S. Typhimurium. Overrepresented Gene Ontology (GO) terms within upregulated and 674 
downregulated genes following growth in 3% bile for each strain. 675 
 676 
Figure 2. Gene expression in response to bile differs between Salmonella strains. 677 
Comparison of genes upregulated and downregulated in response to bile in S. Typhimurium 678 
(Tm), S. Typhi Ty2 (Ty2) and S. Typhi 129-0238 (H58). 679 
 680 
Figure 3. The effect of bile on SPI-1 expression and activity. (A) Heatmap showing log2 681 
fold change in gene expression for S. Typhimurium (Tm), S. Typhi Ty2 (Ty2) and S. Typhi 682 
129-0238 (H58) across the SPI-1 pathogenicity island and for non-SPI-1 carried effectors. 683 
Asterisks (*) indicate genes significantly affected by bile across all three strains. (B) Western 684 
blots of SipC, SipD and SopE of S. Typhimurium 14028 (Tm), S. Typhi Ty2 (Ty2), and two 685 
H58 clinical isolates (ERL12148 and 129-0238) grown in LB with or without 3% bile; SopE 686 
panels are not shown for S. Typhimurium 14028, as this strain lacks SopE. DnaK was used as 687 
a loading control. A representative blot of two independent repeats is shown. Numbers below 688 
panels indicate fold change in density when compared to LB; all bands were normalised to 689 
their respective DnaK control prior to comparison. (C) Strains grown in LB or 3% bile to late 690 
exponential phase were added to HeLa cells at an MOI 100 for 30 min. The percentage of 691 
intracellular bacteria at 2 h post-infection relative to the inoculum added is shown. n=3, error 692 
bars show SD. Invasion rates of strains were compared by t-test (** = P < 0.01, *** = P < 693 
0.001). 694 
 33 
Figure 4. Effect of bile on hilA and hilD transcription in Salmonella. The reporter activity 695 
(β-galactosidase units) of hilA:lacZ and hilD:lacZ in S. Typhimurium 14028 (A & B) and S. 696 
Typhi Ty2 (C & D) following growth to late exponential phase in LB in the presence or 697 
absence of bile. n=3, error bars show SD. Reporter activity between strains was compared by 698 
t-test (* = P < 0.05, *** = P < 0.001). 699 
 700 
Figure 5. HilD autoregulation in S. Typhi. The reporter activity of a S. Typhi Ty2 701 
hilD:lacZ chromosomal transcriptional reporter strain complemented with HilD (pWSK29-702 
Spec HilD-4HA (HilD)) or an empty vector control (pWSK29-Spec (EV)), was determined 703 
by β-galactosidase assay following growth in LB. n=3, error bars show SD. Reporter activity 704 
between strains was compared by one way ANOVA (*** = P < 0.001). 705 
 706 
Figure 6. Bile promotes HilD stability in S. Typhi. WT S. Typhi Ty2 constitutively 707 
expressing C-terminally 4HA-tagged HilD from (A) S. Typhi Ty2 or (B) S. Typhimurium 708 
14028 was grown in LB with or without bile. 30 µg/ml chloramphenicol was added to stop 709 
protein synthesis, and samples were collected every 10 min. HilD levels were determined via 710 
Western blotting using an anti-HA antibody, and DnaK used as a loading control. A 711 
representative blot of three independent repeats is shown. Half-life measurements are 712 
averaged from three independent repeats, and standard deviation is shown. 713 
 714 
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Figure 7. Proposed model of how bile influences SPI-1 expression in S. Typhi. (A) HilD 715 
is at the top of the SPI-1 regulatory hierarchy, where it regulates its own expression and the 716 
expression of HilA. HilD also regulates expression of the additional regulators HilC and 717 
RtsA, which also control HilA expression. (B) In the absence of bile the turnover of HilD is 718 
high, the expression of hilD is at a basal level and as a result the expression of hilA is low (C) 719 
In the presence of bile HilD is more stable, leading to enhanced expression of hilD, hilA and 720 
thus SPI-1.  721 
  722 
 35 
TABLES 723 
Table 1. Genes upregulated by bile in all strains 724 
   Log2 fold 
change 
Name Locus 
tag 
Product Tm Ty2 H58 
fadI t0475 3-ketoacyl-CoA thiolase 4.12 2.55 2.52 
fadJ t0476 multifunctional fatty acid oxidation complex subunit alpha 3.32 2.06 2.17 
fadE t2541 acyl-CoA dehydrogenase 7.44 4.70 4.18 
fadB t3315 multifunctional fatty acid oxidation complex subunit alpha 7.52 2.92 1.57 
fadA t3316 3-ketoacyl-CoA thiolase 7.66 2.88 1.57 
actP t4179 acetate permease 3.41 1.58 1.27 
- t4180 hypothetical protein 3.44 1.72 1.32 
acs t4181 acetyl-CoA synthetase 3.91 2.11 1.31 
acnA t1625 aconitate hydratase 3.18 1.81 1.59 
argT t0509 lysine-arginine-ornithine-binding periplasmic protein 3.36 2.29 1.33 
argD t1182 
bifunctional succinylornithine transaminase/acetylornithine 
transaminase 5.61 2.72 1.20 
- t0677 gentisate 1,2-dioxygenase 2.51 3.91 3.38 
- t0678 FAA-hydrolase-family protein 2.09 3.21 2.87 
- t0679 glutathione-S-transferase-family protein 2.09 2.89 2.49 
- t0680 salicylate hydroxylase 1.27 2.09 2.03 
- t1787 oxidoreductase 3.62 3.53 1.32 
- t1789 hypothetical protein 3.17 4.04 1.44 
- t1790 N-acetylneuraminic acid mutarotase 2.78 4.07 1.32 
gabT t2687 4-aminobutyrate aminotransferase 5.18 2.93 1.74 
msrA t4462 methionine sulfoxide reductase A 1.68 1.67 1.30 
 725 
 726 
Table 2. Log2 fold change in gene expression determined by RNA-Seq and RT-qPCR  727 
 RNA-Seq RT-qPCR 
Gene 14028 Ty2 129-0238 14028 Ty2 129-0238 
hilD -4.08 1.23 3.15 -3.48 
 (± 0.71) 
1.42  
(± 0.25) 
2.44 
(± 0.73) 
hilA -6.98 1.54 3.67 -6.51 
(± 0.64) 
1.71  
(± 0.39) 
3.37 
(± 0.39) 
prgH -6.36 1.57 4.02 -6.00 
(± 0.74) 
1.68  
(± 0.73) 
4.00 
(± 0.48) 
sopB -6.95 1.11 4.21 -3.85  
(± 0.44) 
1.38  
(± 0.59) 
4.13 
(± 0.27) 
flhD -1.72 1.05 1.33 -1.25  
(± 0.43) 
1.93  
(± 0.38) 
2.31 
(± 1.13) 
 36 
flgA -1.29 1.37 1.70 -0.98  
(± 0.27) 
1.99  
(± 0.44) 
1.37 
(± 0.84) 
fadE 7.44 4.70 4.18 3.55 
 (± 2.13) 
3.75  
(± 0.16) 
4.75 
(± 0.09) 
acs 3.91 2.11 1.31 2.03 
 (± 1.77) 
0.87  
(± 0.67) 
2.37 
(± 0.59) 
± indicates standard deviation 728 
 729 
Table 3. Genes downregulated in S. Typhimurium and upregulated in S. Typhi in bile 730 
   Log2 fold change 
Name Locus tag Product Tm Ty2 H58 
fliO t0899 flagellar biosynthesis protein FliO -1.87 1.57 1.35 
fliN t0900 flagellar motor switch protein FliN -1.55 1.44 1.62 
fliM t0901 flagellar motor switch protein FliM -1.71 1.40 1.71 
fliL t0902 flagellar basal body protein FliL -1.74 1.41 1.78 
fliK t0903 flagellar hook-length control protein -1.67 1.33 2.08 
fliJ t0904 flagellar biosynthesis chaperone -1.37 1.43 2.25 
fliI t0905 flagellum-specific ATP synthase -1.43 1.25 1.69 
fliH t0906 flagellar assembly protein H -1.45 1.41 1.57 
fliG t0907 flagellar motor switch protein G -1.44 1.34 1.53 
fliF t0908 flagellar MS-ring protein -1.89 1.32 1.41 
fliE t0909 flagellar hook-basal body protein FliE -2.49 1.76 2.01 
flhD t0952 transcriptional activator FlhD -1.72 1.05 1.33 
flgJ t1738 flagellar rod assembly protein/muramidase FlgJ -1.56 1.30 1.38 
flgI t1739 flagellar basal body P-ring biosynthesis protein 
FlgA -1.69 1.41 1.39 
flgH t1740 flagellar basal body L-ring protein -1.71 1.42 1.68 
flgC t1745 flagellar basal body rod protein FlgC -1.86 1.39 1.79 
flgB t1746 flagellar basal-body rod protein FlgB -2.05 1.40 1.73 
flgA t1747 flagellar basal body P-ring biosynthesis protein 
FlgA -1.29 1.37 1.70 
sprB t2768 AraC family transcriptional regulator -3.76 1.97 4.11 
sprA t2769 AraC family transcriptional regulator -3.29 1.97 3.29 
- t2770 hypothetical protein -3.69 1.22 2.11 
orgA t2771 oxygen-regulated invasion protein -3.90 1.34 1.79 
orgA t2772 oxygen-regulated invasion protein -5.65 1.62 3.50 
prgJ t2774 pathogenicity island 1 effector protein -6.05 1.43 3.83 
prgI t2775 pathogenicity island 1 effector protein -6.15 1.41 3.89 
prgH t2776 pathogenicity island 1 effector protein -6.36 1.57 4.02 
hilA t2778 invasion protein regulator -6.98 1.54 3.67 
iagB t2779 cell invasion protein -6.64 1.35 3.83 
sicP t2781 chaperone -3.06 1.40 3.19 
- t2782 hypothetical protein -3.10 1.56 2.98 
 37 
sipF/iacP t2783 acyl carrier protein -5.62 1.46 3.43 
sipA t2784 pathogenicity island 1 effector protein -5.84 1.55 3.60 
sipD t2785 pathogenicity island 1 effector protein -6.24 1.48 3.87 
spaS t2789 surface presentation of antigens protein SpaS -5.70 1.24 3.29 
spaQ t2791 virulence-associated secretory protein -7.26 1.40 3.00 
spaP t2792 surface presentation of antigens protein SpaP -6.87 1.43 3.25 
spaO t2793 surface presentation of antigens protein SpaO -6.72 1.60 3.66 
spaN t2794 antigen presentation protein SpaN -6.66 1.58 3.91 
spaM t2795 virulence-associated secretory protein -6.91 1.76 3.83 
spaL/invC t2796 ATP synthase SpaL -6.61 1.53 3.43 
Spak/invB t2797 virulence-associated secretory protein -6.04 1.91 4.01 
invA t2798 virulence-associated secretory protein -6.50 1.40 3.34 
invE t2799 cell invasion protein -6.86 1.35 3.59 
invG t2800 virulence-associated secretory protein -7.12 1.37 3.60 
invF t2801 AraC family transcriptional regulator -6.97 1.27 3.84 
invH t2802 cell adherance/invasion protein -4.54 1.57 2.97 
sopD t2846 hypothetical protein -3.76 1.05 4.33 
rtsB t4220 GerE family regulatory protein -7.59 1.99 3.58 
rtsA t4221 AraC family transcriptional regulator -7.33 1.80 3.83 
- t0944 lipoprotein -2.25 1.20 2.22 
- t1774 hypothetical protein -2.09 1.46 2.60 
lpxR t1208 hypothetical protein -7.02 1.19 3.44 
srfA t1503 virulence effector protein -1.75 1.64 1.81 
srfB t1504 virulence effector protein -1.48 1.58 1.88 
 731 
Table 4. Strains and plasmids used in this study 732 
Strain or plasmid Identifier Genotype or comments Source 
Strains    
S. Typhimurium    
14028 ICC797 WT (64) 
14028 ICC1765 ΔhilA:lacZ KanR This study 
14028 ICC1764 ΔhilD:lacZ KanR This study 
S. Typhi    
Ty2 ICC1500 WT G. Dougan 
Ty2  ICC1630 ΔhilA:lacZ KanR This study 
Ty2 ICC1762 ΔhilD:lacZ KanR This study 
Ty2 ICC1556 ΔinvA KanR (64) 
Ty2 ICC1756 Δpat KanR This study 
 38 
CT18 ICC1502 WT G. Dougan 
129-0238 ICC1503 WT, H58 isolate G. Dougan (21) 
ERL12148 ICC1504 WT, H58 isolate G. Dougan (21) 
    
Plasmids    
pKD4 pICC893 Kanamycin cassette template 
plasmid 
(63) 
p3138 pICC2515 LacZ and kanamycin cassette 
template plasmid 
(41) 
pKD46 pICC1298 Lambda red recombinase 
plasmid 
(63) 
pWSK29-Spec E.V. pICC2489 Empty vector, spectinomycinR (64) 
pWSK29-Spec HilD-
4HA Ty2 
 S. Typhi Ty2 HilD-4HA, 
constitutive promoter 
This study 
pWSK29-Spec HilD 
4HA Tm 
 S. Typhimurium 14028 HilD-
4HA, constitutive promoter 
This study 
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